Literature DB >> 19191335

Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production.

Eui Young So1, Byung S Kim.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) infection directly induces many proinflammatory genes, including type I interferon (IFN) and a variety of cytokine genes. These virus-induced cytokines are a critical factor in developing TMEV-induced demyelinating disease. We have previously reported that the major activation signal for the cytokine genes is mediated via TLR3. In this study, we describe that TLR2 is upregulated via TLR3 signal and cooperatively participates in the expression of IL-6, IL-1beta, CCL2, and CCL5 genes following TMEV infection. The expression of these genes was significantly impaired in both TLR2-deficient and TLR3-deficient primary astrocytes. However, the induction of type I IFNs was not affected by TLR2 deficiency in the primary cells. TMEV infection led to TLR2-mediated NF-kappaB activation, but not IRF3 or IRF7 activation, critical for type I IFN production. More importantly, TLR3 was required for TMEV-induced early TLR2 upregulation in primary astrocytes leading to the production of TLR2-dependent cytokines such as IL-6. Interestingly, soluble factor(s) produced via TLR2/3-dependent signals appears to be partially associated with the downstream cytokine production. These results indicate that TMEV utilizes TLR3-induced TLR2 to induce inflammatory cytokines, which are critical to the development of immune-mediated demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191335      PMCID: PMC2706926          DOI: 10.1002/glia.20843

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  52 in total

Review 1.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

3.  Cultured astrocytes express toll-like receptors for bacterial products.

Authors:  Christal C Bowman; Amy Rasley; Susanne L Tranguch; Ian Marriott
Journal:  Glia       Date:  2003-09       Impact factor: 7.452

4.  Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli.

Authors:  Pamela A Carpentier; Bryan R Williams; Stephen D Miller
Journal:  Glia       Date:  2007-02       Impact factor: 7.452

5.  Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

Authors:  Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

6.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

7.  Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3.

Authors:  Eui Young So; Min Hyung Kang; Byung S Kim
Journal:  Glia       Date:  2006-06       Impact factor: 7.452

8.  Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4.

Authors:  Kathy Triantafilou; Martha Triantafilou
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 9.  The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies.

Authors:  Marjelo Mines; Yun Ding; Guo-Huang Fan
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 10.  Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.

Authors:  M C Dal Canto; R W Melvold; B S Kim; S D Miller
Journal:  Microsc Res Tech       Date:  1995-10-15       Impact factor: 2.769

View more
  24 in total

Review 1.  Intercellular Communication Is Key for Protective IFNα/β Signaling During Viral Central Nervous System Infection.

Authors:  Mihyun Hwang; Cornelia C Bergmann
Journal:  Viral Immunol       Date:  2018-09-15       Impact factor: 2.257

2.  Activation of innate immune responses in the central nervous system during reovirus myelitis.

Authors:  Stephanie A Schittone; Kalen R Dionne; Kenneth L Tyler; Penny Clarke
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  Young Hee Jin; Hyun Seok Kang; Wanqiu Hou; Liping Meng; Byung S Kim
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

4.  Melanoma differentiation-associated gene 5 is critical for protection against Theiler's virus-induced demyelinating disease.

Authors:  Young-Hee Jin; Seung Jae Kim; Eui Young So; Liping Meng; Marco Colonna; Byung S Kim
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

Review 5.  The role of chemokines during viral infection of the CNS.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

6.  The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus.

Authors:  Young-Hee Jin; Wanqiu Hou; Hyun Seok Kang; Chang-Sung Koh; Byung S Kim
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.

Authors:  Kevin D Pavelko; Michael P Bell; Lavakumar Karyampudi; Michael J Hansen; Kathleen S Allen; Keith L Knutson; Larry R Pease
Journal:  Mol Ther       Date:  2013-04-09       Impact factor: 11.454

8.  Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.

Authors:  Wanqiu Hou; Young-Hee Jin; Hyun Seok Kang; Byung S Kim
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

Review 9.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

Review 10.  Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Byung S Kim
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.